Continuous Regional Application of Protease Inhibitor in the Treatment of Acute Pancreatitis: An Experimental Study Using Closed Duodenal Obstruction Model in Dogs

Pancreatology

Volumn 1, Issue 6, 2001, Pages 662-667

  Yamauchi, Jun Ichiro ^a   Takeda, Kazunori ^a   Shibuya, Kazuhiko ^a   Sunamura, Makoto ^a   Matsuno, Seiki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute pancreatitis; Intra arterial application; Pancreatic necrosis; Protease inhibitor

Indexed keywords

GUANIDINE DERIVATIVE; NAFAMSTAT; PROTEINASE INHIBITOR; TRYPSIN;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL; ARTICLE; DISEASE MODEL; DOG; DUODENUM OBSTRUCTION; ENZYMOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; METABOLISM; NECROSIS; PATHOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DUODENAL OBSTRUCTION; GUANIDINES; INFUSIONS, INTRA-ARTERIAL; NECROSIS; PANCREATITIS, ACUTE NECROTIZING; PROTEASE INHIBITORS; TRYPSIN;

EID: 0035552961     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055878     Document Type: Article

References (23)

1. Steer ML: The early intraacinar cell events which occur during acute pancreatitis. Pancreas 1998;17:31-37.
2. Hartwig W, Jimenez RE, Werner J, Lewandrowski KB, Warshaw AL, Fernandez-del Castillo C: Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats. Gastroenterology 1999;117:717-725.
3. Göke B, Stockmann F, Muller R, Lankisch PG, Creutzfeldt W: Effect of a specific serine protease inhibitor on the rat pancreas: Systemic administration of camostate and exocrine pancreatic secretion. Digestion 1984;30:171-178.
4. Hirano T, Manabe T: A new synthetic protease inhibitor, nafamostat mesilate (FUT-175) prevents cellular and lysosomal fragility during caerulein-induced acute pancreatitis in the rat. Surg Res Commun 1992;13:67-77.
5. Otani T, Atomi Y, Kuroda A, Muto T, Tamura M, Fukuda S, Akao S, Gorelick FS: Distribution of a synthetic protease inhibitor in rat pancreatic acini after supramaximal secretagogue stimulation. Pancreas 1997;14:142-149.
6. Aoyama T, Ino Y, Ozeki M, Oda M, Sato T, Koshiyama Y, Suzuki S, Fujita M: Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments. Jpn J Pharmacol 1984;35: 203-227.
7. Iwaki M, Ino Y, Motoyoshi A, Ozeki M, Sato T, Kurumi M, Aoyama T: Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Jpn J Pharmacol 1986;41:155-162.
8. Pfeffer RB, Stasior O, Hinton JW: The clinical picture of the sequential development of acute hemorrhagic pancreatitis in the dog. Surg Forum 1957;8:248-251.
9. 1H-imidazol-2-yl) amino]benzoate dimethanesulphonate and its metabolites in biological fluids. J Chromatogr 1988;433:177-186.
10. Messori A, Rampazzo R, Scroccaro G, Olivato R, Bassi C, Falconi M, Pederzoli P, Martini N: Effectiveness of gabexate mesilate in acute pancreatitis: A metaanalysis. Dig Dis Sci 1995;40: 734-738.
11. Büchler M, Malfertheiner P, Uhl W, Scholmerich J, Stockmann F, Adler G, Gaus W, Rolle K, Beger HG: Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology 1993;104:1165-1170.
12. 2 activation by gabexate mesilate. Klin Wochenschr 1989;67:160-162.
13. 2 by gabexate mesilate, camostate, and aprotinine. Klin Wochenschr 1989;67:149-152.
14. Adler G, Reinshagen M, Göke B: Effect of camostat on exocrine pancreatic function in humans. Biomed Res 1989;10:1-7.
15. 2 in human acute pancreatitis. Gastroenterology 1989;97:1521-1526.
16. Büchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG: Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis: Results of a prospective clinical study. Int J Pancreatol 1986;1: 227-235.
17. Sunamura M, Yamauchi J, Shibuya K, Chen HM, Ding L, Takeda K, Kobari M, Matsuno S: Pancreatic microcirculation in acute pancreatitis. J Hepatobil Pancreat Surg 1998;5:62-68.
18. Menger MD, Bonkhoff H, Vollmar B: Ischemia-reperfusion-induced pancreatic microvascular injury: An intravital fluorescence microscopic study in rats. Dig Dis Sci 1996;41: 823-830.
19. Yanamoto H, Kikuchi H, Sato M, Shimizu Y, Yoneda S, Okamoto S: Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 1992;30:358-363.
20. Yanamoto H, Kikuchi H, Okamoto S, Nozaki K: Preventive effect of synthetic serine protease inhibitor, FUT-175, on cerebral vasospasm in rabbits. Neurosurgery 1992;30:351-356
21. Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH: Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 1993;265:G165-G171.
22. Tountas C, Kiriakou K, Marselos A, Carapistolis E: Local intra-arterial infusion of antienzymes in the treatment of acute pancreatitis. Surgery 1966;60:1235-1241.
23. Nugent FW, Bulan MB, Zuberi S: Arterial infusion of antienzymes in the treatment of experimental pancreatitis. Am J Dig Dis 1969;14: 415-419.